Rising Prevalence of Neurological Diseases Driving the Neuromodulation Devices Market Growth; to Witness a CAGR of 10.3% during 2019-2025

NEW YORK, June 04, 2019 (GLOBE NEWSWIRE) -- The global neuromodulation devices market is expected to grow significantly from USD 5,120 Million in 2018 to USD 10,200 Million in 2025, at a CAGR of 10.3% from 2019 to 2025. Factors driving the market growth are; rising prevalence of neurological diseases across the globe, government initiative for product approvals and investments, and rising geriatric population across the globe. In addition, growing use in SCS technology, increasing awareness for neuromodulation, and new product launches are further boosting the industry growth.

Neuromodulation devices are advanced medical tools that improve nervous system activities. Neuromodulation devices affect every area of the body and treat nearly every disease such as spinal cord damage, headaches, tremors, and urinary incontinence, among others. Moreover, these devices have a broad therapeutic scope, and significant ongoing improvements in biotechnology sector are resulting in major growth of the market. 

Additionally, there is an increased demand for neuromodulation devices due to growing aging population which suffers from diseases such as Parkinson, epilepsy, Alzheimer’s, and spinal cord injury. The therapies for these diseases are dominated by neuromodulation devices. Moreover, clinical evidence supporting the use of neurostimulation to treat multiple conditions and growing investments in product development is further driving the industry growth.

Browse full research report with TOC on " Global Neuromodulation Devices Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025" at: https://www.energiasmarketresearch.com/global-neuromodulation-devices-market-report/

To purchase report: sales@energiasmarketresearch.com

Key findings from the report:

• The global neuromodulation devices market is expected to reach USD 10,200 Million by 2025 at a CAGR of 10.3% during 2019-2025

• Based on Technology,

  • The Spinal Cord Stimulation (SCS) segment held the major share of the market in 2018. The growth is attributed to the advancements in technologies, improving implantation techniques, and growing awareness.
  • The Deep Brain Stimulation (DBS) segment is expected to emerge as the fastest growing technology over the forecast period

• On the basis of Application, the Pain Management segment held the major share of the market in 2018

• Geographically, Asia-Pacific region is expected to witness highest CAGR during the 2019-2025

• Some of the key companies operating in the market include Medtronic; NeuroPace, Inc.; Abbot; Boston Scientific Corporation; ALEVA NEUROTHERAPEUTICS SA; Stimwave LLC; Nevro Corp.; Integer Holdings Corporation; Bioness Inc.; and LivaNova PLC, among others

The report provides the market value for the base year 2018 and a yearly forecast till 2025 in terms of revenue (USD Million). The report segments neuromodulation devices market on the basis of technology, application, end-user, and region.

By Technology

• Internal Neuromodulation

  • Deep Brain Stimulation (DBS)
  • Sacral Nerve Stimulation (SNS)
  • Spinal Cord Stimulation (SCS)
  • Vagus Nerve Stimulation (VNS)
  • Gastric Electrical Stimulation (GES)

• External Neuromodulation

  • Transcranial Magnetic Stimulation 
  • Transcutaneous Electrical Nerve Stimulation
  • Respiratory Electrical Stimulation 

By Application

  • Pain Management
  • Parkinson's
  • Urinary and Fecal Incontinence
  • Dystonia
  • Depression
  • Epilepsy
  • Others

By End-User

  • Hospitals
  • Home Setting
  • Clinics

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Central & South America
  • Middle East and Africa (MEA)

Find more research reports on Healthcare Industry, by Energias Market Research:

  • Embolization Coil Market - The global embolization coil market is expected to witness a CAGR of 4.7%, and is projected to reach USD 1,003.7 Million by 2023. Factors propelling the growth of the embolization coil market include increasing knowledge of embolization coil amongst patients, emerging new technologies and minimally invasive alternatives to traditional treatments.
  • Telemedicine Market - The global telemedicine market is expected to grow significantly from USD 19.94 billion in 2016 to USD 54.52 billion in 2023, at a CAGR of 15.5% from 2017 to 2023.Factors such as shortage of specialist physician in the rural areas, and growing aging population coupled with high prevalence of chronic diseases are propelling the growth of the global telemedicine market. Moreover, increasing investment for advanced healthcare IT infrastructure and government initiative towards healthcare are boosting the growth of the telemedicine market. However, lack of trained professionals, and high technological cost are inhibiting the growth of the market.
  •  Anticancer Drug Market - Global Anticancer Drug Market is expected to reach USD 145.2 Billion by 2023, at a CAGR of 6.7% from 2017 to 2023. The growth of the anticancer drug market is attributed to the growing awareness towards cancer diagnosis and treatment, and increasing incidence of targeted disease (cancer, skin cancer, and oral cancer among others), coupled with increasing research and development activities. However, high prices of treatment may hamper the growth of the global anticancer drug market.

About Energias Market Research Pvt. Ltd. -

Energias Market Research launched with the objective to provide in-depth market analysis, business research solutions, and consultation that is tailored to our client’s specific needs based on our impeccable research methodology.

With a wide range of expertise from various industrial sectors and more than 50 industries that include energy, chemical and materials, information communication technology, semiconductor industries, healthcare and daily consumer goods, etc. We strive to provide our clients with a one-stop solution for all research and consulting needs.

Our comprehensive industry-specific knowledge enables us in creating high quality global research outputs. This wide-range capability differentiates us from our competitors.


Mr. Alan Andrews

Business Development Manager

For any queries email us: info@energiasmarketresearch.com

To purchase report: sales@energiasmarketresearch.com

Call us: +1-716-239-4915

Visit: https://www.energiasmarketresearch.com/